Any real-time PCR assay for SARS-CoV-2 RNA may be used as a read-out for Ct values to determine the viral weight of the assay. a 50% tissue culture infective dose (TCID50) of Vero cells. For the microneutralization assay, 19 serum samples, with positive IgG titers against Spike Receptor-Binding Domain name (RBD) were tested. After 24 hours, infected cells were inspected for the presence of a cytopathic effect, lysed and RNA RT-PCR conducted for SARS-CoV-2. PCR target Ct values were used to determine percent neutralization/inhibition of SARS-CoV-2. == Results == Out of 19 samples, 13 samples gave 100% neutralization at all dilutions, 1 sample showed neutralization at the first dilution, 4 samples showed neutralization at lower dilutions, while one sample did not demonstrate any neutralization. The RBD ODs and neutralization potential percentages were found to be positively correlated. == Conclusion == We describe a rapid RT-PCR-based SARS-CoV-2 microneutralization assay for the detection of neutralizing antibodies. This can effectively be used to test the antiviral activity of serum antibodies for the investigation of both disease-driven and vaccine-induced responses. == Introduction == The first cases of SARS-CoV-2 contamination KPT 335 were reported in the city of Wuhan, China on December 1, 2019, aspneumoniawith an unknown etiology [1,2]. The first reported case outside the Chinese territory followed within months in Thailand and on March 11th,2020, SARS-CoV-2 was declared apandemic[1,2]. Globally, as of Rabbit Polyclonal to FMN2 June 7, 2021, SARS-CoV-2 KPT 335 has infected 172 630 637 individuals, while 3 718 683 deaths have been recorded (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). SARS-CoV-2 is an RNA computer virus that uses the human angiotensinconverting enzyme 2 (ACE2) receptor to infect host cells [3,4]. Attachment to ACE2 and subsequent access of SARS-CoV-2 is usually mediated by the Spike glycoprotein via the receptor-binding domain name (RBD) [3,4]. Spike protein is a target for antiviral antibodies, and the RBD domain name, in particular, is the major focus for neutralizing antibodies [36]. Studies have shown that patients who recovered from KPT 335 COVID-19 or, those who are vaccinated, maintain a high antibody titer against the Spike/RBD protein [37]. However, individuals can get re-infected with SARS-CoV-2, suggesting that not all antibodies to S protein have the capacity to neutralize or are not long-lasting enough to give a durable response [810]. Focused studies on neutralizing antibodies KPT 335 in infected or vaccinated individuals are of significant value, as a correlation between antibody titers and computer virus neutralization is essential to measure the efficacy of the vaccination programs, especially against emerging variants [8,1113]. There are several live computer virus neutralization assays in use, where the most common one is based on a plaque reduction neutralization test [4]. These assays require an agarose overlay, which makes the assay laborious to perform. Other live-virus neutralization assays are ELISA-based which are more effective than the plaque assays but still involve antibody labeling and processing actions [4]. Pseudotype computer virus assays are an alternative to live computer virus assays however, these give an approximation of the actual computer virus and may not represent the naturally circulating or newly emerging strains [4]. Here, we describe a neutralizing assay for SARS-CoV-2 using a real-time PCR-based assay output that can be completed within 24 hours and can effectively be used to test neutralization potential of antibodies against viruses including emerging antibody escape variants. == Materials and methods == == Sample collection == Serum was separated from blood taken from convalescent individuals after four weeks of their recovery from COVID-19. The samples were collected after obtaining knowledgeable consent from your patients. This study was approved by Aga Khan University or college, Ethical Review Committee (ERC# 2020-5152-11688). == Cell culture, computer virus isolation and propagation == Vero cells (ATCC CCL-81) were cultured in T25cm2flasks made up of DMEM media supplemented with 10% Fetal Calf Serum (FCS), 1% L-glutamine 200mM, 1% penicillin G (100U/ml), streptomycin (100ug/ml) at 37C and 5% CO2until 8090 confluency was achieved. Nasopharyngeal swab (NPS) in viral transport medium from a PCR-positive SARS-CoV-2 case from June 2020, during the first wave of COVID-19 in Pakistan, was utilized for computer virus isolation. The particular viral isolate has not been sequenced but our data from that time period recognized the G clade strains to be predominant in Pakistan (https://www.biorxiv.org/content/10.1101/2020.08.04.234153v1). Fifty microliters of serum-free DMEM were pipetted into columns 212 of a 96-well tissue culture plate; subsequently, 100L of clinical specimens were pipetted into column 1 and serially diluted 2-fold across the plate (columns 212; from.
Any real-time PCR assay for SARS-CoV-2 RNA may be used as a read-out for Ct values to determine the viral weight of the assay
